These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35740662)

  • 21. Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin.
    Inagaki FF; Kato T; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Choyke PL; Kobayashi H
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32937841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
    Furumoto H; Okada R; Kato T; Wakiyama H; Inagaki F; Fukushima H; Okuyama S; Furusawa A; Choyke PL; Kobayashi H
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-Infrared Photoimmunotherapy for Oropharyngeal Cancer.
    Nishikawa D; Suzuki H; Beppu S; Terada H; Sawabe M; Hanai N
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
    Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
    Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.
    Taki S; Matsuoka K; Nishinaga Y; Takahashi K; Yasui H; Koike C; Shimizu M; Sato M; Sato K
    J Immunother Cancer; 2021 Oct; 9(11):. PubMed ID: 34725216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: Challenges and potentials for human applications.
    Paraboschi I; Turnock S; Kramer-Marek G; Musleh L; Barisa M; Anderson J; Giuliani S
    Crit Rev Oncol Hematol; 2021 May; 161():103325. PubMed ID: 33836238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond.
    Wei D; Qi J; Hamblin MR; Wen X; Jiang X; Yang H
    Theranostics; 2022; 12(16):7108-7131. PubMed ID: 36276636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial near-infrared photoimmunotherapy: effective treatment areas and light doses needed for use with fiber optic diffusers.
    Okuyama S; Nagaya T; Sato K; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Oncotarget; 2018 Feb; 9(13):11159-11169. PubMed ID: 29541404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
    Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
    Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near infrared photoimmunotherapy for lung metastases.
    Sato K; Nagaya T; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Lett; 2015 Aug; 365(1):112-21. PubMed ID: 26021765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy.
    Ogata F; Nagaya T; Okuyama S; Maruoka Y; Choyke PL; Yamauchi T; Kobayashi H
    Oncotarget; 2017 Nov; 8(61):104295-104302. PubMed ID: 29262641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy.
    Kato T; Okada R; Goto Y; Furusawa A; Inagaki F; Wakiyama H; Furumoto H; Daar D; Turkbey B; Choyke PL; Takakura H; Inanami O; Ogawa M; Kobayashi H
    ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1689-1701. PubMed ID: 34661083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.